General Transaction Statement for Mitosol
The chain of custody for Mitosol is very simple, and as such, the document below is applicable for all lots shipped after May 16th, 2016.
Mobius Therapeutics, LLC™ (the drug manufacturer) certifies that we are transferring ownership of the Mitosol lot and quantity specified on the Packing List to an authorized trading partner (Foundation Care), as required under DSCSA, and that we do not knowingly shipping a suspect or illegitimate product, that we do not knowingly provide false transaction information, and that we do not knowingly alter the transaction history.
As the manufacturer, we initiate the Transaction Information and Transaction History; that information can be found on the Packing List accompanying every shipment. There is no prior transaction history requiring verification on our part.
The general chain of custody for every Mitosol product shipped is as follows:
The Transaction Information, Transaction History and Transaction Statement required by DSCSA all appear on the Packing List accompanying every shipment.
WMI-030 Rev 01/2018